HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,223 | -61.5% | 6,209 | -48.9% | 0.00% | – |
| Q2 2023 | $231,545 | -82.1% | 12,161 | -80.1% | 0.00% | -100.0% |
| Q1 2023 | $1,295,352 | +42.8% | 61,217 | -0.4% | 0.00% | 0.0% |
| Q4 2022 | $907,268 | +557.4% | 61,468 | +439.4% | 0.00% | – |
| Q3 2022 | $138,000 | +4500.0% | 11,395 | +2784.8% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 395 | -30.0% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 564 | -29.1% | 0.00% | – |
| Q4 2021 | $7,000 | -30.0% | 795 | -46.4% | 0.00% | – |
| Q1 2021 | $10,000 | -65.5% | 1,482 | -64.8% | 0.00% | – |
| Q4 2020 | $29,000 | +314.3% | 4,211 | +217.6% | 0.00% | – |
| Q3 2020 | $7,000 | -58.8% | 1,326 | -58.7% | 0.00% | – |
| Q2 2020 | $17,000 | -52.8% | 3,208 | -65.8% | 0.00% | – |
| Q1 2020 | $36,000 | +140.0% | 9,380 | +374.2% | 0.00% | – |
| Q4 2019 | $15,000 | +1400.0% | 1,978 | +691.2% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 250 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -97.8% | 250 | -98.7% | 0.00% | – |
| Q1 2019 | $92,000 | – | 18,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,140,000 | $29,171,000 | 4.84% |
| Ophir Asset Management Pty Ltd | 1,670,817 | $15,522,000 | 2.73% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 378,389 | $3,515,000 | 1.16% |
| Birchview Capital, LP | 180,000 | $1,672,000 | 1.00% |
| Diametric Capital, LP | 82,443 | $766,000 | 0.55% |
| Precision Wealth Strategies, LLC | 65,530 | $609,000 | 0.52% |
| Uniplan Investment Counsel, Inc. | 507,602 | $4,715,000 | 0.28% |
| BARD ASSOCIATES INC | 86,315 | $802,000 | 0.26% |
| EAM Investors, LLC | 142,272 | $1,322,000 | 0.20% |
| Zebra Capital Management LLC | 15,786 | $147,000 | 0.17% |